When appetite suppression is so strong that youre consistently undereating (taking in far fewer calories than your body needs), your system may begin to adapt in ways that slow your progress
The most effective approach is lifestyle changes, including a healthy, calorie-controlled diet and regular exercise
NIDDK Emerging Therapies and Oral GLP-1 Options Eli Lillys development of orforglipron, an oral GLP-1 receptor agonist, marks a significant advancement in diabetes treatment
The American Diabetes Association (ADA) Standards of Care and American College of Physicians (ACP) guidelines support the use of GLP-1 receptor agonists, including dual agonists like tirzepatide, as effective options for glycemic control and weight management
Starting GLP-1 too early may increase nausea, vomiting, or surgical complications
Historically, Medicare Part D has generally not covered medications used only for weight loss